Who is sponsoring NCT06161467?

NCT06161467 is sponsored by Assiut University.

What drugs are being tested in NCT06161467?

Interventions in NCT06161467: Ultrasound devices.

What condition does NCT06161467 study?

NCT06161467 studies Ultrasound Therapy; Complications.

Is NCT06161467 still recruiting?

NCT06161467 is currently status unknown. Last updated 8 December 2023.

Last reviewed 2023-12-08 · How we verify

NCT06161467

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transcutaneous Laryngeal Ultrasound as an Alternative to Direct Flexible Laryngoscopy in Assessment of Vocal Cords

Status unknown Last updated 8 December 2023

What this trial tests

trial testing Ultrasound devices in Ultrasound Therapy; Complications in 46 participants. Status unknown.

Timeline

1 December 2023

Primary endpoint
1 November 2025

1 December 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	46
Start date	1 December 2023
Primary completion	1 November 2025
Estimated completion	1 December 2025

Drugs / interventions tested

Ultrasound devices

Conditions studied

Ultrasound Therapy; Complications — all drugs for Ultrasound Therapy; Complications →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Ultrasound Therapy; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the diagnostic value of ultrasound in the assessment of the vocal cords compared with direct flexible laryngoscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ultrasound Therapy; Complications

Currently open trials in the same condition.

NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting
NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
NCT06264167 — NODE (groiN ultrasOunD cancEr) · NA · recruiting
NCT06241716 — Ultrasound-assisted Versus Real-time Ultrasound-guided Combined Spinal-epidural Anesthesia in Elderly Patients · NA · recruiting
NCT05769517 — Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06161467 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 8 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06161467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing